Antidepressant Recall: Wrong Pills Packaged

A precautionary recall has been issued for a specific batch of Sertraline 100mg film-coated tablets, announced on April 28. The action stems from a manufacturing error where two different antidepressant medications were packaged incorrectly. Amarox Limited is recalling batch number V2500425.

The Medicines and Healthcare products Regulatory Agency (MHRA) is directing healthcare professionals to halt the supply of this batch and return all remaining stock. This recall was initiated following a patient complaint that revealed a sealed carton of Sertraline 100mg contained a blister strip of Citalopram 40mg.

Both Sertraline and Citalopram are selective serotonin reuptake inhibitors (SSRIs) used to treat depression and anxiety. The error is believed to have occurred during the secondary packaging process at the manufacturing site. Patients who may have inadvertently taken Citalopram 40mg or are experiencing any heightened serotonergic side effects, such as nausea or headache, should seek immediate medical consultation.

Dr. Alison Cave, MHRA Chief Safety Officer, urged patients to verify their medication packaging for batch number V2500425. If the inner blister strips are labeled Citalopram 40mg, patients should contact their pharmacy promptly. If labeled Sertraline 100mg, no action is necessary. Healthcare providers are actively identifying and contacting potentially affected patients to discuss treatment reviews and necessary prescriptions.